A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
Clinical trial NCT04905212 · TERMINATED
Trial details
- NCT number
- NCT04905212
- Sponsor
- RemeGen Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2023-11-09
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.